» Articles » PMID: 16375670

Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes

Overview
Specialty Pharmacology
Date 2005 Dec 27
PMID 16375670
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Candida species, in particular C. albicans, represent a major threat to immunocompromised patients. Able to exist as a commensal on mucosal surfaces of healthy individuals, these opportunistic fungi frequently cause superficial infections of mucosae and skin. Furthermore, in hospital settings, Candida species may cause life-threatening invasive infections in a growing population of vulnerable patients. In fact, candidaemia is associated with the highest crude mortality of all bloodstream infections. Candida cells may enter the bloodstream by direct penetration from epithelial tissues, due to damage of barriers in the body caused by surgery, polytrauma or drug treatment, or may spread from biofilms produced on medical devices. From the bloodstream, cells may infect almost all organs but appear to prefer certain organs depending upon the route of infection. The exact mechanisms by which Candida cells survive the challenge of the blood environment and escape from the bloodstream to cause deep-seated infections have not yet been elucidated, but various investigations are reviewed. It is clear, however, that Candida must have particular attributes which enable the organism to survive and grow within the environment of healthy individuals and to invade tissues in the immunocompromised host. Most studies have focussed on C. albicans and this review will therefore summarise work on the various known virulence factors and methods used to identify further virulence attributes of this fungus.

Citing Articles

Deep Cutaneous Candidiasis With Costal Osteomyelitis Following Pectoralis Major Myocutaneous Flap Reconstruction: A Case Report.

Goda H, Nakashiro K, Hino S, Kuribayashi N, Uchida D Cureus. 2025; 17(1):e78210.

PMID: 40027028 PMC: 11871034. DOI: 10.7759/cureus.78210.


An 11-Year retrospective analysis of candidiasis epidemiology, risk factors, and antifungal susceptibility in a tertiary care hospital in China.

Khan S, Cai L, Bilal H, Khan M, Fang W, Zhang D Sci Rep. 2025; 15(1):7240.

PMID: 40021727 PMC: 11871059. DOI: 10.1038/s41598-025-92100-x.


Candida albicans cells exhibit media specific proteomic profiles during induction of filamentation.

Veronique L, Veronique A, Guillaume C, Jean-Michel C, Francoise A BMC Microbiol. 2024; 24(1):500.

PMID: 39592958 PMC: 11600622. DOI: 10.1186/s12866-024-03627-4.


Review and Current Perspectives on DNA Topoisomerase I and II Enzymes of Fungi as Study Models for the Development of New Antifungal Drugs.

Andrade-Pavon D, Gomez-Garcia O, Villa-Tanaca L J Fungi (Basel). 2024; 10(9).

PMID: 39330389 PMC: 11432948. DOI: 10.3390/jof10090629.


End-organ damage from neonatal invasive fungal infection: a 14-year retrospective study from a tertiary center in China.

Han T, Qiu M, Niu X, Wang S, Wang F, Cao J BMC Infect Dis. 2024; 24(1):521.

PMID: 38783182 PMC: 11119303. DOI: 10.1186/s12879-024-09360-7.